To say that investors were disappointed with Thursday’s first-quarter earnings report from Nike Inc. (NYSE: NKE) is stating the obvious. Shares tumbled by around 10% in after-hours trading and opened down nearly 12% on Friday. While high inventory levels get a lot of the blame, the company faces a number of other challenges to get back on track.

Quarterly sales of $12.69 billion actually beat the consensus estimate of around $12.29 billion on the strength of full-price realizations on new seasonal apparel, and earnings per share (EPS) came in a penny above the consensus estimate of $0.92. The trouble starts in the company’s second quarter, ending in November.

The company forecast revenue growth for fiscal 2023 was slightly lower than expected, dropping from up 6% to 8% to a new range in the low to mid-single digits. Forecast gross margin and EBIT were also cut based on expected markdowns of nearly 25% to clear out existing inventory. Currency exchange headwinds doubled from previous guidance for a 4% dip to a new forecast of an 8% hit. Two other bright spots for the quarter were a less-than-expected decline in the company’s China business and its solid growth in direct sales to consumers.

Here is a look at how several analysts reacted to Nike’s outlook.

Morgan Stanley maintained an Overweight rating on the stock but cut the 12-month price target from $129 to $120. The firm said that Nike’s updated guidance was “relatively conservative.” The company’s topline growth outlook for the second half of the year drops to flat year over year compared to the first half outlook that calls for year-over-year growth of 7%. Operating income, forecast to decline by 18% year over year in the first half of the year, is expected to drop by 29% in the second half. Nike is also guiding EBIT margin to 150 basis points below the level seen in the 2009 recession.

On the one hand, a “meaningful” recession could make that worse, in Morgan Stanley’s opinion, sending revenue and EBIT down more than currently expected. On the other hand, if Nike’s full-year guidance meets expectations for the current quarter, revenue for the year could rise to around $51.5 billion, nearly 17% higher than 2022 sales, and EBIT margin could rise by more than 13% year over year.

Nike’s decision to take its inventory medicine in the second quarter works in the company’s favor, according to Morgan Stanley, because the short-term hit to gross margins “ensure[s] a cleaner future marketplace and premium positioning.” Nike also remains committed to its direct-to-consumer business, an area that saw sales growth of 8% year over year in the first quarter.

Bank of America Global Research analyst Lorraine Hutchinson reiterated her Neutral rating on the stock and cut the $122 price objective to $100. BofA thinks that Nike is “not out of the woods” yet in China, despite management’s upbeat comments on prospects for a solid second half in the country.

Faster-than-expected recovery in China and better-than-expected margin improvement as Nike continues its exit from “undifferentiated retail channels” could push BofA’s price objective higher. On the downside, the target could fall if Chinese cotton boycotts have a larger-than-expected negative impact, if transitioning to a more digital-centric model is more costly than expected, and if markets continue to boost “value over growth names.”

Kate McShane and her team at Goldman Sachs reiterated their Buy rating but cut Nike’s price target from $120 to $98. Nike’s current valuation looks “attractive relative to historical price levels,” and that, combined with the company’s product innovations (particularly in shoes) and its success in winnowing its Chinese inventory, provides the basis for the rating.

Again, inventory issues get a close look. Nike’s aggressive plan to clear its inventory overhang will pressure gross margins for the rest of the year, Goldman said, “but will allow the company to align their seasonal inventory and product assortment with consumer preferences and demand trends.” In other words, the sooner the pain, the sooner the gain.

J.P. Morgan’s Matthew Boss and his team maintained an Overweight rating on the stock but cut the December 2023 price target from $130 to $120. Boss models fiscal 2023 EPS at $3.20, more than 6% higher than the consensus. In addition, Boss’s team sees a “fundamental risk/reward range of $91 (20x our CY24 EPS = 5-year trough multiple) by $120 (26.5x our CY24 EPS = 5-year pre-pandemic multiple avg).”

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Nike’s September sales in North America and EMEA (Europe, Middle East, Africa) are up by double digits, including “strong” back-to-school sales. Management also noted that promotional pricing meant to clear the inventory of out-of-season gear contributed to the top-line surprise in the first quarter but was not one of the big swing factors.

Despite the upbeat comments, Nike stock traded down by nearly 10.5% in the late morning Friday, at $85.38 in a 52-week range of $82.50 to $179.10. The low was posted early in the morning. Investors do not appear to be as patient as analysts, especially with inflation and a possible recession looming.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.